AAAAAA

   
Results: 1-16 |
Results: 16

Authors: KAWANO Y TAKAUE Y WATANABE A TAKEDA O ARAI K ITOH E OHNO Y TESHIMA T HARADA M WATANABE T OKAMOTO Y ABE T KAJIUME T MATSUSHITA T IKEDA K ENDO M KURODA Y ASANO S TANOSAKI R YAMAGUCHI K LAW P MCMANNIS JD
Citation: Y. Kawano et al., PARTIALLY MISMATCHED PEDIATRIC TRANSPLANTS WITH ALLOGENEIC CD34(-CELLS FROM A RELATED DONOR() BLOOD), Blood, 92(9), 1998, pp. 3123-3130

Authors: MORI T MURATA M WAKUI M MUTO A ISHIDA A TANOSAKI R OKAMOTO S IKEDA Y
Citation: T. Mori et al., ACQUIRED DYSFIBRINOGENEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, American journal of hematology, 56(4), 1997, pp. 294-295

Authors: TANOSAKI R MIGLIACCIO AR
Citation: R. Tanosaki et Ar. Migliaccio, ENGRAFTMENT OF NORMAL STEM-CELLS IN W W-V MICE ASSESSED BY A NOVEL QUANTITATIVE PCR ANALYSIS/, British Journal of Haematology, 98(4), 1997, pp. 1017-1025

Authors: TANOSAKI R SCARADAVOU A ADAMSON JW SOTIROPOULOS D
Citation: R. Tanosaki et al., INFUSED MEGAKARYOCYTES SUPPORT PLATELET PRODUCTION IN CARBOPLATIN-INDUCED THROMBOCYTOPENIC MICE, Blood, 90(10), 1997, pp. 759-759

Authors: ENDO M YOKOYAMA J IKAWA H WATANABE K UEDA M KITAJIMA M KINOSHITA A KUROSAWA Y TANOSAKI R
Citation: M. Endo et al., TREATMENT OF HIGH-RISK SOLID TUMORS OF CHILDHOOD WITH MYELOABLATIVE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION EXPERIENCE, Oncology Reports, 3(3), 1996, pp. 519-525

Authors: ISHIDA A MIYAKAWA Y TANOSAKI R WAKUI M UENO H WATANABE R AWAYA N TAHARA T KATO T MIYAZAKI H ODA A KIZAKI M OKAMOTO S IKEDA Y
Citation: A. Ishida et al., CIRCULATING ENDOGENOUS THROMBOPOIETIN, INTERLEUKIN-3, INTERLEUKIN-6 AND INTERLEUKIN-11 LEVELS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROWTRANSPLANTATION, International journal of hematology, 65(1), 1996, pp. 61-69

Authors: KAJUMO F TANOSAKI R MIGLIACCIO AR
Citation: F. Kajumo et al., ESTABLISHMENT OF A QUANTITATIVE PCR ANALYSIS TO ACCESS ENGRAFTMENT OFNORMAL STEM-CELLS IN W W-V MICE/, Experimental hematology, 24(9), 1996, pp. 29-29

Authors: ALESPEITI G KAJUMO F TANOSAKI R MIGLIACCIO G MIGLIACCIO AR
Citation: G. Alespeiti et al., BONE-MARROW RECONSTITUTION IN NON-MYELOBLATED W W-V MICE/, Experimental hematology, 24(9), 1996, pp. 30-30

Authors: WAKUI M OKAMOTO S ISHIDA A TANOSAKI R MORI T KAWAI Y OHSHIMA S IKEDA Y
Citation: M. Wakui et al., DURABLE MOLECULAR REMISSION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND HOST-DERIVED HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(4), 1996, pp. 801-804

Authors: OKAMOTO S ISHIDA A WAKUI M TANOSAKI R ODA A IKEDA Y
Citation: S. Okamoto et al., PROLONGED THROMBOCYTOPENIA AFTER ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND LEUKAPHERESIS IN A DONOR FOR ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 18(2), 1996, pp. 482-483

Authors: OKAMOTO S TAKAHASHI S TANOSAKI R SAKAMAKI H ONOZAWA Y OH H MIYAWAKI S KIMURA Y TOYAMA K IKEDA Y ASANO S
Citation: S. Okamoto et al., GRANISETRON IN THE PREVENTION OF VOMITING INDUCED BY CONDITIONING FORSTEM-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED STUDY, Bone marrow transplantation, 17(5), 1996, pp. 679-683

Authors: TANOSAKI R ASHIHARA E MIGLIACCIO G MIGLIACCIO AR
Citation: R. Tanosaki et al., MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA) AND LEUKEMIA INHIBITORY FACTOR (LIF) PROTECT THE ENGRAFTMENT POTENTIAL OF ENRICHED MURINE HEMATOPOIETIC STEM-CELLS (HSC) DURING EX-VIVO EXPANSION WITH INTERLEUKIN-3 (IL-3) AND STEM-CELL FACTOR (SCF), Blood, 88(10), 1996, pp. 1369-1369

Authors: WAKUI M OKAMOTO S ISHIDA A TANOSAKI R YAJIMA T IWAO Y HISAMATSU T HIBI T IKEDA Y
Citation: M. Wakui et al., CLINICAL-SIGNIFICANCE OF UPPER GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 1664-1664

Authors: TANOSAKI R OKAMOTO S AKATSUKA N ISHIDA A MICHIKAWA N MASUDA Y UCHIDA H MURATA M KIZAKI M IKEDA Y
Citation: R. Tanosaki et al., DOSE-ESCALATION OF BIWEEKLY CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISOLONE USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA, Cancer, 74(7), 1994, pp. 1939-1944

Authors: KIZAKI M IKEDA Y TANOSAKI R NAKAJIMA H MORIKAWA M SAKASHITA A KOEFFLER HP
Citation: M. Kizaki et al., EFFECTS OF NOVEL RETINOIC ACID COMPOUND, 9-CIS-RETINOIC ACID, ON PROLIFERATION, DIFFERENTIATION, AND EXPRESSION OF RETINOIC ACID RECEPTOR-ALPHA AND RETINOID-X RECEPTOR-ALPHA RNA BY HL-60 CELLS, Blood, 82(12), 1993, pp. 3592-3599

Authors: TANOSAKI R OKAMOTO S AKATSUKA N KAWAI Y IKEDA Y
Citation: R. Tanosaki et al., DOSE-ESCALATION STUDY OF BIWEEKLY CHOP USING RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING-FACTOR (RHG-CSF) IN NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000144-10000144
Risultati: 1-16 |